Centre for Research in Ageing and Cognitive Health, University of Exeter, Exeter, UK.
School of Dementia Studies, University of Bradford, Bradford, UK.
Int J Geriatr Psychiatry. 2019 May;34(5):709-721. doi: 10.1002/gps.5076. Epub 2019 Mar 1.
To determine whether individual goal-oriented cognitive rehabilitation (CR) improves everyday functioning for people with mild-to-moderate dementia.
Parallel group multicentre single-blind randomised controlled trial (RCT) comparing CR added to usual treatment (CR) with usual treatment alone (TAU) for people with an ICD-10 diagnosis of Alzheimer, vascular or mixed dementia, and mild-to-moderate cognitive impairment (Mini-Mental State Examination [MMSE] score ≥ 18), and with a family member willing to contribute. Participants allocated to CR received 10 weekly sessions over 3 months and four maintenance sessions over 6 months. Participants were followed up 3 and 9 months post randomisation by blinded researchers. The primary outcome was self-reported goal attainment at 3 months. Secondary outcomes at 3 and 9 months included informant-reported goal attainment, quality of life, mood, self-efficacy, and cognition and study partner stress and quality of life.
We randomised (1:1) 475 people with dementia; 445 (CR = 281) were included in the intention to treat analysis at 3 months and 426 (CR = 208) at 9 months. At 3 months, there were statistically significant large positive effects for participant-rated goal attainment (d = 0.97; 95% CI, 0.75-1.19), corroborated by informant ratings (d = 1.11; 95% CI, 0.89-1.34). These effects were maintained at 9 months for both participant (d = 0.94; 95% CI, 0.71-1.17) and informant (d = 0.96; 95% CI, 0.73-1.2) ratings. The observed gains related to goals directly targeted in the therapy. There were no significant differences in secondary outcomes.
CR enables people with early-stage dementia to improve their everyday functioning in relation to individual goals targeted in the therapy.
确定个体化导向认知康复(CR)是否能改善轻中度痴呆患者的日常功能。
一项平行组、多中心、单盲、随机对照试验(RCT),将 CR 联合常规治疗(CR)与单纯常规治疗(TAU)进行比较,入组人群为 ICD-10 诊断为阿尔茨海默病、血管性或混合性痴呆且存在轻度至中度认知障碍(简易精神状态检查量表[MMSE]评分≥18),且其家属愿意参与的患者。CR 组患者接受 10 周共 3 个月的每周 1 次治疗和 6 个月的 4 次维持治疗,随机分组后 3 个月和 9 个月由盲法研究者进行随访。主要结局为 3 个月时的自我报告目标达成情况。次要结局包括 3 个月和 9 个月时的报告者报告目标达成情况、生活质量、情绪、自我效能、认知和研究伙伴的压力和生活质量。
我们按 1:1 比例随机分配了 475 名痴呆患者,445 名(CR=281 名)患者在 3 个月时纳入意向治疗分析,426 名(CR=208 名)患者在 9 个月时纳入意向治疗分析。在 3 个月时,患者自评的目标达成情况具有统计学显著的较大积极效应(d=0.97;95%CI,0.75-1.19),报告者的评价结果也支持这一结论(d=1.11;95%CI,0.89-1.34)。这些效应在 9 个月时对患者(d=0.94;95%CI,0.71-1.17)和报告者(d=0.96;95%CI,0.73-1.2)的评价均保持一致。观察到的增益与治疗中直接针对的目标相关。次要结局无显著差异。
CR 使处于早期阶段的痴呆患者能够在与治疗中直接针对的目标相关的日常功能方面得到改善。